Emeryville, CA, United States of America

Vivien Wai-Fan Chan

USPTO Granted Patents = 6 


Average Co-Inventor Count = 6.9

ph-index = 3

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Vivien Wai-Fan Chan

Introduction

Vivien Wai-Fan Chan is a prominent inventor based in Emeryville, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody-T cell receptor chimeric constructs. With a total of 6 patents to his name, Chan's work is paving the way for advancements in targeted therapies.

Latest Patents

One of Chan's latest patents focuses on antibody-TCR chimeric constructs. This patent provides detailed information about constructs that comprise an antibody moiety specifically designed to bind to a target antigen. These constructs are fused to a TCRM capable of recruiting at least one TCR-associated signaling module. The application also outlines methods for making and utilizing these innovative constructs.

Career Highlights

Vivien Wai-Fan Chan is currently associated with Eureka Therapeutics, Inc., where he continues to push the boundaries of scientific research and innovation. His work is instrumental in developing new therapeutic strategies that could potentially revolutionize treatment options for various diseases.

Collaborations

Chan collaborates with talented individuals in his field, including Hong Liu and Yiyang Xu. These partnerships enhance the research environment and contribute to the successful development of groundbreaking technologies.

Conclusion

Vivien Wai-Fan Chan's contributions to biotechnology through his innovative patents and collaborations highlight his role as a leading inventor in the industry. His work continues to inspire advancements in targeted therapies and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…